| Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study S Hernández-Díaz, S Toh, S Cnattingius Bmj 338, b2255, 2009 | 755 | 2009 |
| The US Food and Drug Administration's Mini‐Sentinel program: status and direction R Platt, RM Carnahan, JS Brown, E Chrischilles, LH Curtis, S Hennessy, ... Pharmacoepidemiology and drug safety 21, 1-8, 2012 | 356 | 2012 |
| Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study D Arterburn, R Wellman, A Emiliano, SR Smith, AO Odegaard, S Murali, ... Annals of internal medicine 169 (11), 741-750, 2018 | 274 | 2018 |
| Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System S Toh, ME Reichman, M Houstoun, MR Southworth, X Ding, ... Archives of internal medicine 172 (20), 1582-1589, 2012 | 262 | 2012 |
| Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1. 0 SV Wang, S Schneeweiss, ML Berger, J Brown, F Vries, I Douglas, ... Pharmacoepidemiology and Drug Safety 26 (9), 1018-1032, 2017 | 213 | 2017 |
| Guidelines for Good Pharmacoepidemiology Practice (GPP) Public Policy Committee Pharmacoepidemiology and drug safety 25 (1), 2-10, 2016 | 160 | 2016 |
| Data quality assessment for comparative effectiveness research in distributed data networks JS Brown, M Kahn, S Toh Medical care 51, S22-S29, 2013 | 159 | 2013 |
| Comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass: the National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study KM McTigue, R Wellman, E Nauman, J Anau, RY Coley, A Odor, J Tice, ... JAMA surgery 155 (5), e200087-e200087, 2020 | 157 | 2020 |
| Prevalence and trends in the use of antipsychotic medications during pregnancy in the US, 2001–2007: a population-based study of 585,615 deliveries S Toh, Q Li, TC Cheetham, WO Cooper, RL Davis, S Dublin, TA Hammad, ... Archives of women's mental health 16 (2), 149-157, 2013 | 151 | 2013 |
| Potential bias of instrumental variable analyses for observational comparative effectiveness research LF Garabedian, P Chu, S Toh, AM Zaslavsky, SB Soumerai Annals of internal medicine 161 (2), 131-138, 2014 | 148 | 2014 |
| Causal inference from longitudinal studies with baseline randomization S Toh, MA Hernán The international journal of biostatistics 4 (1), Article 22, 2008 | 140 | 2008 |
| Validity of health plan and birth certificate data for pregnancy research SE Andrade, PE Scott, RL Davis, DK Li, D Getahun, TC Cheetham, ... Pharmacoepidemiology and Drug Safety, 2012 | 138 | 2012 |
| Coronary Heart Disease in Postmenopausal Recipients of Estrogen Plus Progestin Therapy: Does the Increased Risk Ever Disappear? S Toh, S Hernández-Díaz, R Logan, JE Rossouw, MA Hernán Annals of internal medicine 152 (4), 211-217, 2010 | 138 | 2010 |
| Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments … C Cameron, B Fireman, B Hutton, T Clifford, D Coyle, G Wells, ... Systematic reviews 4 (1), 1-8, 2015 | 132 | 2015 |
| Selective serotonin reuptake inhibitor use and risk of gestational hypertension S Toh, AA Mitchell, C Louik, MM Werler, CD Chambers, ... Am J Psychiatry 166 (3), 320-328, 2009 | 129 | 2009 |
| Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study S Toh, C Hampp, ME Reichman, DJ Graham, S Balakrishnan, F Pucino, ... Annals of internal medicine 164 (11), 705-714, 2016 | 123 | 2016 |
| Pregnancy-associated cancer: a US population-based study CM Cottreau, I Dashevsky, SE Andrade, DK Li, L Nekhlyudov, MA Raebel, ... Journal of Women's Health 28 (2), 250-257, 2019 | 107 | 2019 |
| Statins and fracture risk. A systematic review S Toh, S Hernández‐Díaz Pharmacoepidemiology and drug safety 16 (6), 627-640, 2007 | 105 | 2007 |
| Use of real‐world evidence in regulatory decisions for rare diseases in the United States—Current status and future directions J Wu, C Wang, S Toh, FE Pisa, L Bauer Pharmacoepidemiology and drug safety 29 (10), 1213-1218, 2020 | 101 | 2020 |
| Validation of an algorithm to estimate gestational age in electronic health plan databases Q Li, SE Andrade, WO Cooper, RL Davis, S Dublin, TA Hammad, ... Pharmacoepidemiology and drug safety 22 (5), 524-532, 2013 | 101 | 2013 |
Pamala A. PawloskiSr Research Investigator, HealthPartners Institute在 healthpartners.com 的电子邮件经过验证
